CROI 2024 Program Guide

Poster Sessions

683

Role of Dolutegravir in the Emergence of the S147G Integrase Resistance Mutation Marc Wirden, Basma Abdi , Sidonie Lambert-Niclot, Marie-Laure Chaix, Anne de Monte, Brigitte Montes, Coralie Pallier, Pantxika Bellecave, Magali Bouvier-Alias, Stephanie Raymond, Sabine Yerly, Charlotte Charpentier, Vincent Calvez, Anne-Genevieve Marcelin, for the French ANRS MIE Resistance Study Group HIV-1 Resistance Mutations to Integrase Inhibitors Impair Both Integration and Reverse Transcription Pauline Ratouit, Vincent Guiraud, Isabelle Malet, Cathia Soulie, Jérome Denis, Ronan Legrand, Elisa Teyssou, Anne-Genevieve Marcelin, Vincent Calvez High-Level Resistance to Integrase Inhibitors Conferred by Mutations Outside Integrase Yuta Hikichi, Sherimay D Ablan, Erin Clark, Eric O. Freed Virologic Failure With Cabotegravir-Rilpivirine Injections: A Single-Site Experience Shivanjali Shankaran, Laura Hernandez-Guarin, Neel Jhobalia, Beverly Sha, Mariam Aziz A Phase II Trial of 4 Weeks of Glecaprevir/Pibrentasvir for Early Hepatitis C Virus: ACTG A5380 Arthur Kim , Minhee Kang, Triin Umbleja, Estevao P Nunes, Kristen Marks, Chanelle Wimbish, Daniel S Fierer, Annie Luetkemeyer, Dimas Kleimann, Sunil Suhas Solomon, Leonard Sowah, Beverly L Alston Smith, David L Wyles, Susanna Naggie, for the A5380 Study Team Precision Randomized Trial of Hepatitis C Treatment Adherence Support Among 3000 PWID in India Shruti H. Mehta , Allison M McFall, Mihili P Gunaratne, Aylur K Srikrishnan, Jiban J Baishya, Ashwini Kedar, Amrose Pradeep, Jayseelan Boobalan, Bryan Lau, Stephan Ehrhardt, David Thomas, Muniratnam S Kumar, Gregory M Lucas, Sunil Suhas Solomon Prevalence and Risk Factors for Hepatitis C Viremia in People With HIV in the US During the DAA Era Jimmy Ma , Robin M Nance, Edward Cachay, Stephanie A Ruderman, Lydia N Drumright, Rob Fredericksen, Oluwaseun Falade-Nwulia, Geetanjali Chander, Christopher Hurt, George A Yendewa, April Pettit, Richard D Moore, Mari Kitahata, H Nina Kim, for the Center for AIDS Research Network of Integrated Clinical Systems Elimination of HCV Among People With HIV in Australia Joanne Carson , Marianne Martinello, Samira Hosseini-Hooshyar, Phillip Read, David A Baker, Jeffrey Post, Robert Finlayson, Mark Bloch, Joseph Doyle, David Shaw, Margaret Hellard, Ecaterina Filep, Gregory Dore, Gail Matthews

Poster Sessions • Monday

684

685

686 LB

Poster Session-I1 | Elimination of Hepatitis C 2:30 PM - 4:00 PM • Poster Hall C-D

696 LB

697 LB

698

NIS 699

CROI 2024 81

New Investigator Scholarship

LB

NIS

Late-Breaking